Fertility and Sterility
Volume 94, Issue 5 , Pages 1700-1706 , October 2010

Clinical application of comprehensive chromosomal screening at the blastocyst stage

  • William B. Schoolcraft, M.D.

      Affiliations

    • Colorado Center for Reproductive Medicine, Lone Tree, Colorado
    • ,
  • Elpida Fragouli, Ph.D.

      Affiliations

    • University of Oxford, Nuffield Department of Obstetrics and Gynaecology, Oxford, United Kingdom
    • Reprogenetics UK, Oxford, United Kingdom
    • ,
  • John Stevens, M.S.

      Affiliations

    • Colorado Center for Reproductive Medicine, Lone Tree, Colorado
    • ,
  • Santiago Munne, Ph.D.

      Affiliations

    • Reprogenetics, Livingston, New Jersey
    • ,
  • Mandy G. Katz-Jaffe, Ph.D.

      Affiliations

    • University of Oxford, Nuffield Department of Obstetrics and Gynaecology, Oxford, United Kingdom
    • ,
  • Dagan Wells, Ph.D., F.R.C.Path.

      Affiliations

    • University of Oxford, Nuffield Department of Obstetrics and Gynaecology, Oxford, United Kingdom
    • Reprogenetics UK, Oxford, United Kingdom
    • Corresponding Author InformationReprint requests: Dr. Dagan Wells, Ph.D., F.R.C.Path., University of Oxford, Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Women's Centre, Oxford OX3 9DU, United Kingdom (FAX: 01865-769141).

Received 25 July 2009 ,Revised 6 October 2009 ,Accepted 7 October 2009.

References 

  1. Kuliev A, Verlinsky Y. Meiotic and mitotic nondisjunction: lessons from preimplantation genetic diagnosis. Hum Reprod Update. 2004;10:401–407
  2. Pellestor F, Andréo B, Anahory T, Hamamah S. The occurrence of aneuploidy in human: lessons from the cytogenetic studies of human oocytes. Eur J Med Genet. 2006;49:103–116
  3. Boué J, Boué A, Lazar P. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions. Teratology. 1975;12:11–26
  4. Menasha J, Levy B, Hirschhorn K, Kardon NB. Incidence and spectrum of chromosome abnormalities in spontaneous abortions: new insights from a 12-year study. Genet Med. 2005;7:251–263
  5. Munné S, Lee A, Rosenwaks Z, Grifo J, Cohen J. Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod. 1993;8:2185–2191
  6. Gianaroli L, Magli MC, Ferraretti AP, Fiorentino A, Garrisi J, Munné S. Preimplantation genetic diagnosis increases the implantation rate in human in vitro fertilization by avoiding the transfer of chromosomally abnormal embryos. Fertil Steril. 1997;68:1128–1131
  7. Munné S, Magli C, Bahçe M, Fung J, Legator M, Morrison L, et al. Preimplantation diagnosis of the aneuploidies most commonly found in spontaneous abortions and live births: XY, 13, 14, 15, 16, 18, 21, 22. Prenat Diagn. 1998;18:1459–1466
  8. Munné S, Magli C, Cohen J, Morton P, Sadowy S, Gianaroli L, et al. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum Reprod. 1999;14:2191–2199
  9. Munné S, Sandalinas M, Escudero T, Velilla E, Walmsley R, Sadowy S, et al. Improved implantation after preimplantation genetic diagnosis of aneuploidy. Reprod Biomed Online. 2003;7:91–97
  10. Munné S, Fischer J, Warner A, Chen S, Zouves C, Cohen J Referring Centers PGD Group. Preimplantation genetic diagnosis significantly reduces pregnancy loss in infertile couples: a multicenter study. Fertil Steril. 2006;85:326–332
  11. Colls P, Escudero T, Cekleniak N, Sadowy S, Cohen J, Munné S. Increased efficiency of preimplantation genetic diagnosis for infertility using “no result rescue.”. Fertil Steril. 2007;88:53–61
  12. Garrisi GJ, Colls P, Ferry KM, Zheng X, Garrisi MG, Munné S. Effect of infertility, maternal age and number of previous miscarriages on the outcome of preimplantation genetic diagnosis for idiopathic recurrent pregnancy loss. Fertil Steril. 2009;92:288–295
  13. Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod. 2004;19:2849–2858
  14. Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, et al. In vitro fertilization with preimplantation genetic screening. N Engl J Med. 2007;357:9–17
  15. Hardarson T, Hanson C, Lundin K, Hillensjö T, Nilsson L, Stevic J, et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Hum Reprod. 2008;23:2806–2812
  16. Munné S, Wells D, Cohen J. Technology requirements for preimplantation genetic diagnosis to improve art outcome. Fertil Steril. Published online April 29, 2009 [Epub ahead of print].
  17. Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obstet Gynecol. 1999;11:307–311
  18. Wells D, Escudero T, Levy B, Hirschhorn K, Delhanty JD, Munné S. First clinical application of comparative genomic hybridization and polar body testing for preimplantation genetic diagnosis of aneuploidy. Fertil Steril. 2002;78:543–549
  19. Kuwayama M. Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology. 2007;67:73–80
  20. Schoolcraft WB, Surrey ES, Gardner DK. Embryo transfer: techniques and variables affecting success. Fertil Steril. 2001;76:863–870
  21. Wells D, Delhanty JD. Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol Hum Reprod. 2000;6:1055–1062
  22. Voullaire L, Slater H, Williamson R, Wilton L. Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization. Hum Genet. 2000;106:210–217
  23. Vanneste E, Voet T, Le Caignec C, Ampe M, Konings P, Melotte C, et al. Chromosome instability is common in human cleavage-stage embryos. Nat Med. 2009;15:577–583
  24. Munné S, Chen S, Colls P, Garrisi J, Zheng X, Cekleniak N, et al. Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online. 2007;14:628–634
  25. Fragouli E, Lenzi M, Ross R, Katz-Jaffe M, Schoolcraft WB, Wells D. Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod. 2008;23:2596–2608
  26. Cohen J, Wells D, Munné S. Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril. 2007;87:496–503
  27. Cohen J, Grifo JA. Multicentre trial of preimplantation genetic screening reported in the New England Journal of Medicine: an in-depth look at the findings. Reprod Biomed Online. 2007;15:365–366
  28. Munné S, Cohen J, Simpson JL. In vitro fertilization with preimplantation genetic screening. N Engl J Med. 2007;357:1769–1770
  29. McArthur SJ, Leigh D, Marshall JT, Gee AJ, De Boer KA, Jansen RP. Blastocyst trophectoderm biopsy and preimplantation genetic diagnosis for familial monogenic disorders and chromosomal translocations. Prenat Diagn. 2008;28:434–442
  30. Munné S, Fragouli E, Colls P, Katz M, Wells D. Comprehensive chromosome screening indicates that an appropriately designed 12-chromosome FISH test would detect 91% of aneuploid blastocysts. RBM Online. 2009;20:92–97
  31. Ho PC. New frontiers of assisted reproductive technology (Chien Tien Hsu Memorial Lecture 2007). J Obstet Gynaecol Res. 2009;35:1–8
  32. Shih W, Rushford DD, Bourne H, Garrett C, McBain JC, Healy DL, et al. Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection. Hum Reprod. 2008;23:1644–1653
  33. Jansen RP, Bowman MC, de Boer KA, Leigh DA, Lieberman DB, McArthur SJ. What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Hum Reprod. 2008;23:1476–1478

 W.S. has nothing to disclose. E.F. has nothing to disclose. J.S. has nothing to disclose. S.M. has nothing to disclose. M.K.-J. has nothing to disclose. D.W. has nothing to disclose.

 The first two authors contributed equally to this work.

 Dr. Wells was funded by the NIHR Biomedical Research Centre Programme.

PII: S0015-0282(09)03875-8

doi: 10.1016/j.fertnstert.2009.10.015

Fertility and Sterility
Volume 94, Issue 5 , Pages 1700-1706 , October 2010

Article Tools

* Image Usage & Resolution